Janus Henderson Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
Janus Henderson Group's KYMR Position: Q3 2026 in Review
Janus Henderson Group increased its Kymera Therapeutics (KYMR) stake by 968% in Q3 2026, buying an estimated $23.4M and bringing the position to 224,961 shares worth $25.2M. The position accounts for 0.01% of the portfolio, ranked #589.
Janus Henderson Group first reported a position in KYMR in Q1 2021 and has held it in 18 quarters since. 301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- Janus Henderson Group held 224,961 shares of Kymera Therapeutics worth $25.2M as of Q3 2026.
- Janus Henderson Group bought 203,903 Kymera Therapeutics shares in Q3 2026, an estimated $23.4M.
- Kymera Therapeutics made up 0.01% of Janus Henderson Group's portfolio in Q3 2026, its #589 holding.
- Janus Henderson Group first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 18 quarters since.
- 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.